DHS 157.13(5)(a)3.3. In addition to the requirements in this paragraph and par. (b), an application for a license or amendment for medical use of radioactive material as described in s. DHS 157.70 shall also include information regarding any radiation safety aspects of the medical use of the material that is not addressed in ss. DHS 157.59 to 157.62, identification of and commitment to follow the applicable radiation safety program requirements in ss. DHS 157.63 (1) to 157.67 (1) that are appropriate for the specific s. DHS 157.70 medical use, as well as any specific information on each of the following: DHS 157.13(5)(a)3.c.c. Methodology for measurement of dosages or doses to be administered to patients or human research subjects. DHS 157.13(5)(a)3.d.d. Calibration, maintenance and repair of instruments and equipment necessary for radiation safety. DHS 157.13(5)(a)4.4. An applicant for a license for mobile services shall assure that release of individuals or human research subjects to whom radioactive drugs or implants containing radioactive material are administered will be released under s. DHS 157.62 (8). DHS 157.13(5)(a)5.5. The applicant or licensee shall provide any other information requested by the department in its review of the application. DHS 157.13(5)(b)(b) License amendment. An application for a license amendment shall meet all of the following requirements: DHS 157.13(5)(b)1.1. A licensee shall apply for and must receive a license amendment before the licensee does any of the following: DHS 157.13(5)(b)1.a.a. Receives or uses radioactive material for a type of use that is permitted under this subchapter, but that is not authorized on the licensee’s current license issued under this subchapter. DHS 157.13(5)(b)1.b.b. Permits anyone to work as an authorized user, authorized nuclear pharmacist, ophthalmic physicist, or authorized medical physicist under the license, except an individual who is certified by a specialty board appropriate to the intended use of radioactive material and recognized by the NRC; or is named as an authorized user, authorized nuclear pharmacist, ophthalmic physicist, or authorized medical physicist on a department, NRC or other agreement state license, or on a permit issued by a licensee who is authorized by a Type A license of broad scope to permit the medical use of radioactive material. DHS 157.13(5)(b)1.d.d. Permits anyone to work as an associate radiation safety officer, or before the radiation safety officer assigns duties and tasks to an associate radiation safety officer that differ from those for which the associate radiation safety officer is authorized on the license. DHS 157.13(5)(b)1.e.e. Receives radioactive material in excess of the amount or in a different form or receives a different radionuclide than is authorized on the license DHS 157.13(5)(b)1.f.f. Adds to or changes the areas identified in the application or on the license, except for areas where radioactive material is used only under ss. DHS 157.63 (1) and (2). DHS 157.13(5)(b)1.i.i. Receives a sealed source from a different manufacturer or of a different model number than authorized by its license unless the sealed source is used for manual brachytherapy, is listed in the Sealed Source and Device Registry, and is in a quantity and for an isotope authorized by the license. DHS 157.13(5)(c)(c) Notifications. A licensee shall make all of the following notifications: DHS 157.13(5)(c)1.1. Provide to the department a copy of the board certification, the NRC or agreement state license, or other equivalent permit or license for each individual no later than 30 days after the date that the licensee permits the individual to work as an authorized user, an authorized nuclear pharmacist, an ophthalmic physicist, or an authorized medical physicist under par. (b) 1. b. For individuals permitted to work under par. (b) 1. b., within the same 30 day time frame, the licensee shall also provide, as appropriate, verification of completion of all the following: DHS 157.13(5)(c)1.b.b. Training in device operation, safety procedures, and clinical use for the type of use for which authorization is sought. This training requirement may be satisfied by satisfactory completion of a training program provided by the vendor for new users or by receiving training supervised by an authorized user or authorized medical physicist, as appropriate, who is authorized for the type of use for which the individual is seeking authorization as an authorized user under s. DHS 157.67 (1). DHS 157.13(5)(c)1.c.c. Training for the type of use for which authorization is sought that includes hands-on device operation, safety procedures, clinical use, and the operation of a treatment planning system. This training requirement may be satisfied by satisfactorily successfully completing either a training program provided by the vendor or by training supervised by an authorized medical physicist authorized for the type of use for which the individual is seeking authorization as an authorized medical physicist. DHS 157.13(5)(c)2.2. Notify the department in writing no later than 30 days after any of the following occurs: DHS 157.13(5)(c)2.a.a. An authorized user, an authorized nuclear pharmacist, a radiation safety officer, an associate radiation safety officer, an authorized medical physicist, or an ophthalmic physicist permanently discontinues performance of duties under the license or has a name change. DHS 157.13(5)(c)2.c.c. The licensee’s name changes but the name change does not constitute a transfer of control of the license.